Paul Pharoah Cedars-Sinai Medical Center (United States)

PharoahPaul
I am a research Scientist in the Department of Computational Biomedicine at Cedars Sinai Medical Center, Los Angeles. I qualified in medicine from the University of Oxford in 1986. After a series of posts in internal medicine I worked for a year in Malawi on a leprosy vaccine trial. I then completed my training in public health medicine before taking up a post as research fellow in the CRC Human Cancer Genetics group at the University of Cambridge in 1996. Having completed my doctoral studies in 1999 I won a Cancer Research UK Senior Clinical Research Fellowship. On completion of my fellowship in 2009 I was appointed Reader in Cancer Epidemiology and promoted to a personal Chair in 2012, Department of Public Health and Primary Care, University of Cambridge. I moved to Los Angeles in November 2022. My major research interests are i) common genetic variation and breast and ovarian cancer susceptibility ii) the role of germline genotype in determining the clinical and molecular pathological characteristics of breast and ovarian cancer.

Wednesday, 18 June 2025

Time Session
15:20
16:55
Co-Chair: Emilia Lim  (Canada)
Co-Chair: Marisol S. Soengas  (Spain)
  • Polygenic risk models and prevention in breast and ovarian cancer
    Speaker: Paul Pharoah  (United States)
  • Proffered Paper: Selected from Abstracts - to be announced in 2025
  • Mechanisms of Lung Cancer Promotion
    Speaker: William Hill  (United Kingdom)
  • Proffered Paper: Selected from Abstracts - to be announced in 2025
  • Investigating the impact of environmental exposures
    Speaker: Emilia Lim  (Canada)
Auditorium 2